New research and treatments for epilepsy have come a long way in the last several years. In this Q&A, we talk with Seattle Children’s Epilepsy Program and professor of neurology and pediatrics at the University of Washington. As the director of one of the largest epilepsy programs in the nation and the program exclusively dedicated to pediatrics in the Northwest accredited level 4 by the National Association of Epilepsy Centers, Dr. Novotny answers questions about advances in epilepsy treatment., director of
Seattle Children’s Announces Decade-Long “It Starts With Yes” Campaign Surpassed Fundraising Goal With $1.4B Raised
Seattle Children’s launched its $1 billion fundraising initiative, It Starts With Yes: The Campaign For Seattle Children’s to transform childhood health and change the odds for all kid-kind.
At the end of 2021, the Yes campaign closed with greater success than expected, surpassing its initial goal of $1 billion, raising $1.4 billion. Last year alone, donors contributed more than $223.7 million – more than any year in Seattle Children’s fundraising history. Read full post »
Bronchopulmonary dysplasia is a long-lasting form of lung disease affecting babies born prematurely. Their lungs are not fully formed and are sometimes damaged, and they need extra oxygen through a tube placed into their nose or more support to survive, grow and develop.
BPD also is called chronic lung disease of prematurity. The number of newborns with BPD has risen as more and more babies survive being born many weeks before their due date. An estimated 10,000 to 15,000 newborns develop BPD in the United States each year.
In this Q&A, Dr. Gregory Redding, division chief of the Pulmonary and Sleep Medicine Division at Seattle Children’s and professor of pediatrics at the University of Washington, shares details on Seattle Children’s expanding Bronchopulmonary Dysplasia Program.
Seattle Children’s is excited to welcome Dr. Burt Yaszay as the new chief of Orthopedics and Sports Medicine at Seattle Children’s. Yaszay comes to Seattle Children’s with a bright vision for the future as well as a deep respect for the roots in which Seattle Children’s was founded.
We sat down with Yaszay to learn more about his extensive expertise and vision for the program.
Yaszay earned his medical degree at Stanford University School of Medicine and did his residency in general and orthopedic surgery at the University of Washington and a fellowship at NYU Hospital for Joint Diseases. Yaszay most recently spent 14 years at Rady Children’s Hospital in San Diego, which is nationally recognized as one of the best programs in the country.
He is excited to bring his expertise to Seattle Children’s and foster an environment of innovation and collaboration.
Colleen and Derek spent the first half of Colleen’s pregnancy like many first-time parents, imagining what their child would be like, musing about things they would do as a family and celebrating a joyful new chapter in their lives.
They never imagined they would have a child with special needs or that doctors would predict their baby may not live past childhood. When that became Colleen and Derek’s reality, Seattle Children’s Uncompensated Care Fund gave them the gift they needed most — time with their daughter.
Hypospadias (pronounced hype-oh-spay-dee-us) is a birth defect where the opening of the urethra, the tube that carries urine from the bladder to the outside of the body, is not located at the tip of the penis. Depending on the severity of the condition, it can affect the penile function and one’s self-perception. It is a common condition that can be treated with surgery in some cases; however, a decision to proceed with surgery needs to be carefully thought through and discussed among the provider, parents and patients.
The current standard treatment for hypospadias starts with the provider defining the severity of the condition. The severity is based on the location of the urethral meatus, the external opening of the urethra, and the penile curvature. Based on the severity, some patients may be offered surgery as a next step. Surgery involves using local tissue from one part of the patient’s body to relocate the urethral opening to the correct position at the tip of the penis. To date, assessment of the tissue is subjective, and therefore, it is hard for surgeons to repeat the process moving forward.
Dr. Nicolas Fernandez, a pediatric urologist at Seattle Children’s and surgeon scientist at the University of Washington, is working on a research project that aims to reduce this subjectivity and explore new approaches to better assess structural and genetic components of the tissue used for surgery. He is doing so by proposing a novel approach to evaluate hypospadias.
By using technology to detect small genetic differences that can lead to big changes in an individual’s physical characteristics and by applying artificial intelligence on patients with hypospadias, providers can improve clustering of individuals with similar characteristics to ensure a more accurate prediction for treatment and surgery for this condition. This ultimately leads to better, more impactful outcomes for the patient and family.
Dr. Fernandez spoke with On the Pulse about his research.
Sabrina and Reiff Castillote knew something was wrong with their daughter Maleea’s health when she was just 5 days old. Then, their 6-year-old son Malachi’s behavior became concerning.
For over 15 years, Sabrina and Reiff took their children to countless specialists, but they never received a clear diagnosis. “We were told our daughter was considered ‘failure to thrive,’ without any real answers to as to why,” Sabrina said. “Some providers thought Malachi might have autism and ataxia, but not all their symptoms lined up.”
Finally, in 2019, they got an answer.
When Michael Willen, art therapist, was growing up in Boulder, Colorado during the 1990s, he heard lots of talk about accepting those who were different from you. Reality, however, often didn’t align with the talk.
“You couldn’t be openly gay or talk about something like being transgender,” he recalls. “I wanted a community to connect with, but I didn’t have that resource until I went to college. I wondered why we couldn’t have more of that.”
These days, Michael is helping build an open, accepting community for students at theand inpatients at Seattle Children’s. His crowning achievement is Diversity Club, a class at the Alyssa Burnett Center that celebrates diversity and helps students become advocates for equity.
For these reasons, Michael recently received the 2021 Odessa Brown Ken Feldman Award, one of Seattle Children’s highest honors, which recognizes individuals or teams that encourage, promote, and display compassion and advocacy for all people.
The Odessa Brown Children’s Clinic helped establish this award in 2006 to recognize individuals and teams that, beyond their formal job description, model diversity, inclusion, and quality care with dignity. A committee administers the award every year.
Since the start of the COVID-19 pandemic, people have been asking ethical questions about vaccinating children against the disease: Is it necessary to vaccinate children, who seem to experience the disease differently than adults? Should children in school be required to get the vaccine?
We spoke to Dr. Doug Diekema, an emergency medicine physician at Seattle Children’s and director of education in the Treuman Katz Center for Pediatric Bioethics, to discuss these and other questions about vaccinating kids against COVID-19. Read on to learn more.